Company Overview of Neurotech Pharmaceuticals, Inc.
Neurotech Pharmaceuticals, Inc., a biotechnology company, develops sight-saving therapeutics for chronic retinal diseases in the United States. It offers NT-501, which is used for the treatment of geographic atrophy associated with atrophic age-related macular degeneration and retinitis pigmentosa; encapsulated cell technology platform, which allows sustained delivery of therapeutic factors to the back of the eye; and Neurotech Recovery-Back device that controls and treats back pain using transcutaneous electrical nerve stimulation and neuromuscular electrical stimulation. Neurotech Pharmaceuticals, Inc. was formerly known as Neurotech S.A and changed its name in May 2006. The company was fo...
701 George Washington Highway
Lincoln, RI 02865
Founded in 1995
Key Executives for Neurotech Pharmaceuticals, Inc.
Chief Financial Officer and Vice President
Chief Scientific Officer and Vice President of Research & Development- USA
Vice President of Business Development
Director of The National Eye Institute and Principal Investigator
Compensation as of Fiscal Year 2012.
Neurotech Pharmaceuticals, Inc. Key Developments
Neurotech Launches Neurotech Recovery-Back
Jul 25 12
Neurotech is introducing the Neurotech Recovery-Back, an innovative and non-invasive device designed to help manage low back pain and rehabilitate the low back and abdominal muscles. Neurotech Recovery-Back device helps control and treat back pain using two clinically proven therapies, TENS (transcutaneous electrical nerve stimulation) and NMES (neuromuscular electrical stimulation). The comfortable and easy-to-wear device integrates two conductive garments that relieve both chronic and acute low back pain. The patient uses a hand-held controller to control the amount of stimulation delivered to the lower back and abdominal muscles. Neurotech Recovery-Back is cleared by the FDA and is only available by prescription.
Neurotech Hires Dominic D'arpino as National Account Manager
Dec 8 11
Neurotech has recently hired Dominic D'Arpino to join its North American team as National Account Manager for the eastern US region. D'Arpino joins Neurotech after working for eight years with Otto Bock HealthCare. While at Otto Bock, he worked as Western Operations Supervisor, Reimbursement Claims Processing Center Manager, Market Manager and Sales Specialist.
Neurotech Pharmaceuticals, Inc. Presents at BIO China International Conference, Oct-12-2011 03:30 PM
Sep 28 11
Neurotech Pharmaceuticals, Inc. Presents at BIO China International Conference, Oct-12-2011 03:30 PM. Venue: Pudong Shangri-La Hotel, 33 Fu Cheng Rd., Pudong, Shanghai 200120, China.
Similar Private Companies By Industry
Recent Private Companies Transactions
August 27, 2012
May 30, 2012
Most Searched Private Companies
Sponsored Financial Commentaries